HH
Harte Hanks, Inc.
HHS · NASDAQ
$4.22 +1.44% (+$0.06)
1M +69.48%
Market Cap $31.3M
P/E Ratio -
Div. Yield -
ROE 30.13%
Bulios Fair Price
$4.48
6.2% upside
Trenutna cena
$4.22
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica HHS trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
94 /100
Cheap P/B 2.04x
P/S 0.20x
PEG N/A
Growth
9 /100
Declining Book val. growth 2.96%
Rev. growth 8.20%
FCF growth N/A
Profitability
7 /100
Weak FCF margin 0.94%
Op. margin 2.53%
Gross margin 22.72%
Quality
15 /100
Poor Asset turnover 1.76x
ROA 6.49%
ROIC 6.31%
Debt
28 /100
High Current ratio 1.30x
Int. coverage -19.03x
Debt/Equity 1.57x
Stability
43 /100
Moderate Profitable years 0
EPS volatility 1,085.87%
Beta -0.04x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o HHS
Online
Sector
Industrials
Industry
Specialty Business Services
CEO
David Fisher
Employees
1,719
Headquarters
Chelmsford
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report